Work

550P Preclinical characterization of CPL304110 as a potential selective inhibitor of fibroblast growth factors 1/2/3 in solid cancers

Year: 2020

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2020.08.664

Authors: D. Popiel, A. Mikołajczyk, M.M. Skupinska, J. Hucz-Kalitowska, P. Stańczak, N. Piotrkowska, A. Yamani, K. Dubiel, J. Pieczykolan, M. Wieczorek, A. Stanczak

Institution: Celon Pharma (Poland)

Language: English

Topic: Fibroblast Growth Factor Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3089172788

FWCI: 0.143

Cites:

Cited by: 2

Related to: 10